Misonix, Inc. (Misonix), a company developing ultrasonic surgical devices, has formed alliance for three years with Dalpharma, Ltd. (Dalpharma) for the distribution of SonicOne Ultrasonic Wound Debrider. The agreement will allow Dalpharma to distribute SonicOne in Saudi Arabia, Yemen, Oman, and Egypt, and includes minimum purchase requirements.
Dalpharma is a distributor of medical devices and capital equipment, with special emphasis on the wound care market segment.
The company claims that the SonicOne is an innovative, ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures. The SonicOne establishes a new standard in advanced wound care and ensures progress towards patient healing.
“Misonix welcomes Dalpharma to our expanding family of distributors and represents one of our early partnerships in the important Saudi Arabian and Middle East market places,” said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. “Dalpharma’s reputation as a high integrity, customer focused sales organization is well known to Misonix.”